NeuroGenesis Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis (NCT06961383) | NeuroGenesis Ltd. | 2025-10-01 |
Track NeuroGenesis Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.